Blazsek I, Misset J L, Benavides M, Comisso M, Ribaud P, Mathé G
Institut du Cancer et d'Immunogénétique, Université Paris-Sud, France.
Exp Hematol. 1990 May;18(4):259-65.
An increasing amount of data provides strong evidence for the complex multifactorial control of primary hemopoietic functions. Here we present a new multicellular functional unit, the Hematon, isolated from the light-density floating fraction of normal human bone marrow (BM) aspirates. The Hematon is organized in a compact, three-dimensional spheroid complex from central adipocytes, fibroblastoid cells, and resident macrophages that compartmentalize myeloid, erythroid, and megakaryocyte progenitor cells and their progenies. The Hematon fraction is more than twofold more abundant in progenitor cells when compared to the mononuclear cell (MNC) fraction as gauged by cytological techniques and by analysis of granulocyte-macrophage colony-forming unit (GM-CFU) populations. Individual Hematons may produce, within 2-3 weeks, up to 50,000 hemopoietic cells of different cell lineages in organotypic microcultures. Recombinant human hematopoietic growth factors interleukin 3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), and macrophage colony-stimulating factor (M-CSF) significantly stimulated the endogenous cell production of some but not all of the individually treated Hematons, indicating the heterogeneity of factor-responsive cells within the Hematon population. Comparative observations of 184 BM aspirates support the hypothesis that the presence of Hematons in a BM aspirate correlates positively with homeostatic blood cell production, because the Hematon was present in normal BM (31/40) and it was rare among patients with myelodysplastic syndromes (15/53), acute myeloblastic leukemia (7/39), and chronic myelocytic leukemia (5/52). We suggest that the Hematon represents a unifying model around which the variability of fundamental BM functions and dysfunctions can be explored.
越来越多的数据为原发性造血功能的复杂多因素控制提供了有力证据。在此,我们展示了一种新的多细胞功能单元——造血元,它是从正常人骨髓抽吸物的低密度漂浮部分分离出来的。造血元由中央脂肪细胞、成纤维样细胞和驻留巨噬细胞组成紧密的三维球体复合体,这些细胞将髓系、红系和巨核系祖细胞及其后代分隔开来。通过细胞学技术和粒细胞 - 巨噬细胞集落形成单位(GM - CFU)群体分析可知,与单核细胞(MNC)部分相比,造血元部分的祖细胞含量多出两倍以上。在器官型微培养中,单个造血元在2 - 3周内可产生多达50,000个不同细胞系的造血细胞。重组人造血生长因子白细胞介素3(IL - 3)、粒细胞 - 巨噬细胞集落刺激因子(GM - CSF)、粒细胞集落刺激因子(G - CSF)和巨噬细胞集落刺激因子(M - CSF)显著刺激了部分而非所有单独处理的造血元的内源性细胞生成,这表明造血元群体中因子反应性细胞存在异质性。对184份骨髓抽吸物的比较观察支持了以下假设:骨髓抽吸物中造血元的存在与稳态血细胞生成呈正相关,因为造血元存在于正常骨髓中(31/40),而在骨髓增生异常综合征患者(15/53)、急性髓性白血病患者(7/39)和慢性粒细胞白血病患者(5/52)中则很少见。我们认为,造血元代表了一个统一模型,围绕该模型可以探索基本骨髓功能和功能障碍的变异性。